Date Filed | Type | Description |
09/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/25/2023 |
4
| Godshall Douglas Evan (President & CEO) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Sold 1,778 shares
@ $204.36, valued at
$363.4k
Sold 700 shares
@ $205.7, valued at
$144k
Sold 300 shares
@ $206.68, valued at
$62k
Sold 600 shares
@ $207.8, valued at
$124.7k
Sold 505 shares
@ $209.16, valued at
$105.6k
Sold 199 shares
@ $211.29, valued at
$42k
Sold 303 shares
@ $213.15, valued at
$64.6k
Sold 1,204 shares
@ $219.6, valued at
$264.4k
Sold 2,204 shares
@ $220.5, valued at
$486k
Sold 1,707 shares
@ $221.56, valued at
$378.2k
Sold 500 shares
@ $222.61, valued at
$111.3k
|
|
08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/23/2023 |
4
| FRANCIS LAURA (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Sold 497 shares
@ $220.97, valued at
$109.8k
|
|
08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/22/2023 |
4
| WATKINS FRANK T (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Sold 237 shares
@ $216.4, valued at
$51.3k
Sold 400 shares
@ $217.43, valued at
$87k
Sold 1,200 shares
@ $218.9, valued at
$262.7k
Sold 811 shares
@ $220.7, valued at
$179k
Sold 352 shares
@ $221.43, valued at
$77.9k
Exercised 3,000 options
@ $3.416, valued at
$10.2k
|
|
08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/16/2023 |
4
| Toyloy Sara (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Sold 100 shares
@ $223.64, valued at
$22.4k
|
|
08/15/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
08/10/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
08/10/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/07/2023 |
8-K
| Quarterly results
Docs:
|
"Shockwave Medical Reports Second Quarter 2023 Financial Results SANTA CLARA, Calif., Aug. 07, 2023 -- Shockwave Medical, Inc. , a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended June 30, 2023. Recent Highlights Recognized revenue of $180.2 million for the second quarter of 2023, representing an increase of 49% from the same period in 2022 As part of the Fiscal Year 2024 Medicare Hospital Inpatient Prospective Payment System final rule, the Centers for Medicare & Medicaid Services created three new coronary IVL-specific MS-DRGs, which will become effective October 1, 2023. These new codes are associated with higher payments than the MS-DRG payments for o..." |
|
08/04/2023 |
4
| Zacharias Isaac (President, CCO) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Paid exercise price by delivering 232 shares
@ $250.1, valued at
$58k
|
|
08/04/2023 |
4
| PUCKETT DAN (CFO) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Paid exercise price by delivering 210 shares
@ $250.1, valued at
$52.5k
|
|
08/04/2023 |
4
| Phung Trinh (VP, Finance) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Paid exercise price by delivering 115 shares
@ $250.1, valued at
$28.8k
|
|
08/04/2023 |
4
| Godshall Douglas Evan (President & CEO) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Paid exercise price by delivering 614 shares
@ $250.1, valued at
$153.6k
|
|
07/27/2023 |
4
| Zacharias Isaac (President, CCO) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Sold 4,000 shares
@ $268.06, valued at
$1.1M
|
|
07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/06/2023 |
4
| Papiernik Antoine (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Exercised 17,381 options
@ $17, valued at
$295.5k
|
|
06/15/2023 |
4
| Zacharias Isaac (President, CCO) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Paid exercise price by delivering 545 shares
@ $288.9, valued at
$157.5k
|
|
06/15/2023 |
4
| WATKINS FRANK T (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Granted 736 shares
@ $0 |
|
06/15/2023 |
4
| Toyloy Sara (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Granted 736 shares
@ $0 |
|
06/15/2023 |
4
| Sainz Maria (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Granted 736 shares
@ $0 |
|
06/15/2023 |
4
| Papiernik Antoine (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Granted 736 shares
@ $0 |
|
06/15/2023 |
4
| MOLL FREDERIC H (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Granted 736 shares
@ $0 |
|
06/15/2023 |
4
| LARKIN C RAYMOND JR (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Granted 736 shares
@ $0 |
|
06/15/2023 |
4
| FRANCIS LAURA (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Granted 736 shares
@ $0 |
|
06/15/2023 |
4
| Ballinger Kevin J. (Director) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Granted 736 shares
@ $0 |
|
06/01/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
05/30/2023 |
4
| Zacharias Isaac (President, CCO) has filed a Form 4 on Shockwave Medical, Inc.
Txns:
| Sold 4,000 shares
@ $277.53, valued at
$1.1M
|
|
|